Aberrant Factors of Fibrinolysis and Coagulation in Pancreatic Cancer
Open Access
- 1 January 2021
- journal article
- review article
- Published by Taylor & Francis Ltd in OncoTargets and Therapy
- Vol. ume 14, 53-65
- https://doi.org/10.2147/ott.s281251
Abstract
Aberrant factors associated with fibrinolysis and thrombosis are found in many cancer patients, which can promote metastasis and are associated with poor prognosis. The relationship between tumor-associated fibrinolysis and thrombosis is poorly understood in pancreatic cancer. This review provides a brief highlight of existing studies that the fibrinolysis and coagulation systems were activated in pancreatic cancer patients, along with aberrant high concentrations of tissue plasminogen activator (t-PA), urine plasminogen activator (u-PA), D-dimer, fibrinogen, or platelets. These factors cooperate with each other, propelling tumor cell shedding, localization, adhesion to distant metastasis. The relationship between thrombosis or fibrinolysis and cancer immune escape is also investigated. In addition, the potential prevention and therapy strategies of pancreatic cancer targeting factors in fibrinolysis and coagulation systems are also been discussed, in which we highlight two effective agents aspirin and low-molecular weight heparin (LMWH). Summarily, this review provides new directions for the research and treatment of pancreatic cancer.Keywords
This publication has 149 references indexed in Scilit:
- Neutrophil extracellular traps sequester circulating tumor cells and promote metastasisJCI Insight, 2013
- Cell Surface Remodeling by Plasmin: A New Function for an Old EnzymeJournal of Biomedicine and Biotechnology, 2012
- Serum high mobility group box‐1 is a powerful diagnostic and prognostic biomarker for pancreatic ductal adenocarcinomaCancer Science, 2012
- Detection of cathepsin B, cathepsin L, cystatin C, urokinase plasminogen activator and urokinase plasminogen activator receptor in the sera of lung cancer patientsOncology Letters, 2011
- Co-detection of members of the urokinase plasminogen activator system in tumour tissue and serum correlates with a poor prognosis for soft-tissue sarcoma patientsBritish Journal of Cancer, 2010
- A Pilot Study of Urokinase-Type Plasminogen Activator (uPA) Overexpression in the Brush Cytology of Patients with Malignant Pancreatic or Biliary StricturesHPB Surgery, 2009
- Hyaluronan levels during laparoscopic versus open colonic resectionsSurgical Endoscopy, 2007
- Platelet glycoprotein Ibα supports experimental lung metastasisProceedings of the National Academy of Sciences of the United States of America, 2007
- The kringle domain of tissue-type plasminogen activator inhibits in vivo tumor growthBiochemical and Biophysical Research Communications, 2005
- Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelAOncogene, 1999